BD (NYSE:BDX) today announced the commercial launch of its CentroVena One insertion system, a central venous catheter (CVC) ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced that Teleflex and Arrow International LLC are recalling both the Arrow MAC Two-Lumen Central ...
Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these, in ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today proudly announced the ...
Safe and Cost Effective Use of Alteplase for the Clearance of Occluded Central Venous Access Devices
Phase I and Pharmacologic Study of Oral ZD9331, A Novel Nonpolyglutamated Thymidylate Synthase Inhibitor, in Adult Patients With Solid Tumors PURPOSE: To determine whether cryopreserved solutions of ...
The largest study of patients with peripherally inserted central catheters (PICC) utilizing a subcutaneous anchoring securement system (SASS) ever conducted shows that using subcutaneous anchors to ...
Compremium’s Quantis CVP joined the FDA’s Total Product Life Cycle Advisory Program (TAP) after earning Breakthrough Device ...
Warren Buffett, the US financier, famously said, “cost is what you pay, value is what you get.” The clinical study by Weisen et al 1 associated with our editorial puts a spotlight on the highly ...
ASH and ISTH sought to develop clinical practice guidelines on anticoagulant prophylaxis for pediatric patients who are at risk of VTE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results